Search Results - "Al-Rabi K"

3014P Genomic landscape and co-mutation profiles in compound EGFR-mutant non-small cell lung cancer.

Authors: Al-Rabi, K. Yaser, S.A. Tamimi, F.T. et al.

Source: Annals of Oncology. 2025 Supplement 2, Vol. 36, pS1569-S1569. 1p.

3144P Clinico-genomic features of NSCLC patients with non-targetable EGFR mutations: Analysis of MSK-CHORD.

Authors: Hamadneh, Y.I. Zayed, A.M. Al-Rabi, K.

Source: Annals of Oncology. 2025 Supplement 2, Vol. 36, pS677-S677. 1p.

3046eP Co-mutational racial disparities in EGFR positive lung cancer.

Authors: Zayed, A.M. Hamadneh, Y.I. Al-Batsh, T. et al.

Source: Annals of Oncology. 2025 Supplement 2, Vol. 36, pS1579-S1580. 2p.

Osimertinib treatment based on plasma T790M monitoring in patients with EGFR-mutant non-small-cell lung cancer (NSCLC): EORTC Lung Cancer Group 1613 APPLE phase II randomized clinical trial.

Authors: Remon, J. Besse, B. Aix, S. Ponce et al.

Source: Annals of Oncology. May2023, Vol. 34 Issue 5, p468-476. 9p.

2008P Assessing response durability and survival after second-line pembrolizumab in advanced urothelial carcinoma: A multicenter validation of a risk model.

Authors: Salah, S. Kobayashi, T. Ito, K. et al.

Source: Annals of Oncology. 2024 Supplement 2, Vol. 35, pS1159-S1159. 1p.

A rare case report of 8p11 myeloid and lymphoid neoplasm with FGFR1 abnormality in a young adult.

Authors: Shaaban H Dabu J Al-Rabi K et al.

Source: Annals of Hematology. 2013 Jan, Vol. 92 Issue 2, p285-286. 2p.

1509TiP The 1825-EORTC, ALKALINE: Activity of lorlatinib based on ALK resistance mutations on blood in ALK positive NSCLC patients previously treated with second generation ALK inhibitor.

Authors: Mezquita, L. Xenophontos, E. Pretzenbaher, Y. et al.

Source: Annals of Oncology. 2023 Supplement 2, Vol. 34, pS849-S850. 2p.

LBA51 Osimertinib treatment based on plasma T790M monitoring in patients with EGFR-mutant non-small cell lung cancer (NSCLC): EORTC Lung Cancer Group 1613 APPLE phase II randomized clinical trial.

Authors: Masip, J. Remon Besse, B. Aix, S. Ponce et al.

Source: Annals of Oncology. 2022 Supplement 7, Vol. 33, pS1419-S1419. 1p.

Dose adjusted EPOCH-R is superior to RCHOP in frontline treatment of mediastinal large B cell lymphoma.

Authors: Ma'koseh M Yaseen A Abed NA et al.

Source: Hematology (Amsterdam, Netherlands) [Hematology] 2025 Dec; Vol. 30 (1), pp. 2515337. Date of Electronic Publication: 2025 Jun 18.

Publication Type: Journal Article

Journal Info: Publisher: Taylor & Francis Country of Publication: England NLM ID: 9708388 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1607-8454 (Electronic) Linking ISSN: 10245332 NLM ISO Abbreviation: Hematology Subsets: MEDLINE

Outcomes of patients with higher-risk myelodysplastic syndromes/neoplasms treated with hypomethylating agents + venetoclax-an analysis from the International Consortium for MDS (icMDS) VALIDATE database.

Authors: Bewersdorf JP Kewan T Lanino L et al.

Source: Blood cancer journal [Blood Cancer J] 2026 Jun 29. Date of Electronic Publication: 2026 Jun 29.

Publication Type: Journal Article

Journal Info: Publisher: Nature Pub. Group Country of Publication: United States NLM ID: 101568469 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2044-5385 (Electronic) Linking ISSN: 20445385 NLM ISO Abbreviation: Blood Cancer J Subsets: MEDLINE

Prevalence of PD-L1 Expression in Non-Small Cell Lung Cancer: A Real-World Analysis From Jordan.

Authors: El Khatib O Obeidat N Yaseen A et al.

Source: JCO global oncology [JCO Glob Oncol] 2026 May; Vol. 12 (5), pp. e2600114. Date of Electronic Publication: 2026 May 29.

Publication Type: Journal Article; Observational Study

Journal Info: Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 101760170 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2687-8941 (Electronic) Linking ISSN: 26878941 NLM ISO Abbreviation: JCO Glob Oncol Subsets: MEDLINE

Outcomes of Peripheral Blood Haploidentical Stem Cell Transplantation With Post-Transplant Cyclophosphamide and Earlier Initiation of Immunosuppression.

Authors: Ma'koseh M Rahman ZA Yaseen A et al.

Source: Clinical lymphoma, myeloma & leukemia [Clin Lymphoma Myeloma Leuk] 2025 Jul; Vol. 25 (7), pp. e513-e523.e1. Date of Electronic Publication: 2025 Feb 01.

Publication Type: Journal Article

Journal Info: Publisher: Elsevier Country of Publication: United States NLM ID: 101525386 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2152-2669 (Electronic) Linking ISSN: 21522669 NLM ISO Abbreviation: Clin Lymphoma Myeloma Leuk Subsets: MEDLINE

The evolving role of targeted radioligand therapy in small cell and non-small cell lung cancer: a systematic review.

Authors: Moghrabi S Ruzzeh S Al-Rabi K et al.

Source: Exploration of targeted anti-tumor therapy [Explor Target Antitumor Ther] 2026 Apr 27; Vol. 7, pp. 1002368. Date of Electronic Publication: 2026 Apr 27 (Print Publication: 2026).

Publication Type: Journal Article; Systematic Review

Journal Info: Publisher: Open Exploration Country of Publication: United States NLM ID: 101770662 Publication Model: eCollection Cited Medium: Internet ISSN: 2692-3114 (Electronic) Linking ISSN: 26923114 NLM ISO Abbreviation: Explor Target Antitumor Ther Subsets: PubMed not MEDLINE

Aggressive ductal carcinoma presented with bilateral breast superscan on [¹⁸F]FDG PET/CT.

Authors: Abdlkadir AS Estrada-Lobato E Al-Rabi K et al.

Source: Revista espanola de medicina nuclear e imagen molecular [Rev Esp Med Nucl Imagen Mol (Engl Ed)] 2025 Nov-Dec; Vol. 44 (6), pp. 500163. Date of Electronic Publication: 2025 Jun 18.

Publication Type: Journal Article

Journal Info: Publisher: Elsevier España Country of Publication: Spain NLM ID: 101770941 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2253-8089 (Electronic) Linking ISSN: 22538089 NLM ISO Abbreviation: Rev Esp Med Nucl Imagen Mol (Engl Ed) Subsets: MEDLINE; In Process

Clinical Characteristics and Outcomes of CML in Adolescents and Young Adults.

Authors: Al-Rabi K Ma'koseh M Al-Qadi F et al.

Source: Clinical lymphoma, myeloma & leukemia [Clin Lymphoma Myeloma Leuk] 2024 Oct; Vol. 24 (10), pp. 715-723. Date of Electronic Publication: 2024 May 25.

Publication Type: Journal Article

Journal Info: Publisher: Elsevier Country of Publication: United States NLM ID: 101525386 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2152-2669 (Electronic) Linking ISSN: 21522669 NLM ISO Abbreviation: Clin Lymphoma Myeloma Leuk Subsets: MEDLINE

The prognostic utility of ¹⁸F-FDG PET parameters in lymphoma patients under CAR-T-cell therapy: a systematic review and meta-analysis.

Authors: Al-Ibraheem A Abdlkadir AS Al-Adhami DA et al.

Source: Frontiers in immunology [Front Immunol] 2024 Sep 02; Vol. 15, pp. 1424269. Date of Electronic Publication: 2024 Sep 02 (Print Publication: 2024).

Publication Type: Systematic Review; Meta-Analysis; Journal Article

Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE

Lung Cancer in Jordan.

Authors: Al-Rabi K El Khatib O Abdeljalil R et al.

Source: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer [J Thorac Oncol] 2025 Aug; Vol. 20 (8), pp. 1007-1017.

Publication Type: Editorial

Journal Info: Publisher: Elsevier Country of Publication: United States NLM ID: 101274235 Publication Model: Print Cited Medium: Internet ISSN: 1556-1380 (Electronic) Linking ISSN: 15560864 NLM ISO Abbreviation: J Thorac Oncol Subsets: MEDLINE; In Process

Beyond clinical trials: real-world impact of immunotherapy on NSCLC in Jordan.

Authors: Abu Hejleh T AlSawalha K Abdel Hafiz S et al.

Source: Frontiers in oncology [Front Oncol] 2024 Apr 30; Vol. 14, pp. 1369126. Date of Electronic Publication: 2024 Apr 30 (Print Publication: 2024).

Publication Type: Journal Article

Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE

[¹⁷⁷Lu]Lu-FAPI Radioligand Therapy: Emerging Horizons and Clinical Promise in Solid Tumors: A Comprehensive Review.

Authors: Al-Ibraheem A Abdlkadir AS Ruzzeh S et al.

Source: Seminars in nuclear medicine [Semin Nucl Med] 2025 Jul 03. Date of Electronic Publication: 2025 Jul 03.

Publication Type: Journal Article; Review

Journal Info: Publisher: W.B. Saunders Country of Publication: United States NLM ID: 1264464 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1558-4623 (Electronic) Linking ISSN: 00012998 NLM ISO Abbreviation: Semin Nucl Med Subsets: MEDLINE

Bridging borders for resilience in cancer control in the Middle East: a strategic alliance of Saudi Arabia, Qatar, and Jordan.

Authors: Jafar H Alessy SA Subramanian M et al.

Source: The Lancet. Oncology [Lancet Oncol] 2025 Jul; Vol. 26 (7), pp. e390-e397. Date of Electronic Publication: 2025 Jun 11.

Publication Type: Journal Article; Review

Journal Info: Publisher: Lancet Pub. Group Country of Publication: England NLM ID: 100957246 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1474-5488 (Electronic) Linking ISSN: 14702045 NLM ISO Abbreviation: Lancet Oncol Subsets: MEDLINE